Financial results - SANDOZ PHARMACEUTICALS S.R.L.

Financial Summary - Sandoz Pharmaceuticals S.r.l.
Unique identification code: 47071873
Registration number: J40/21304/2022
Nace: 4646
Sales - Ron
114.622.573
Net Profit - Ron
1.920.384
Employees
154
Open Account
Company Sandoz Pharmaceuticals S.r.l. with Fiscal Code 47071873 recorded a turnover of 2024 of 114.622.573, with a net profit of 1.920.384 and having an average number of employees of 154. The company operates in the field of Comerţ cu ridicata al produselor farmaceutice și medicale having the NACE code 4646.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Sandoz Pharmaceuticals S.r.l.

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR - - - - - - - 0 40.989.365 114.622.573
Total Income - EUR - - - - - - - 0 41.110.956 114.823.214
Total Expenses - EUR - - - - - - - 1.236 40.966.785 112.353.303
Gross Profit/Loss - EUR - - - - - - - -1.236 144.171 2.469.911
Net Profit/Loss - EUR - - - - - - - -1.236 -332.886 1.920.384
Employees - - - - - - - 0 80 154
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 181.2%, from 40.989.365 euro in the year 2023, to 114.622.573 euro in 2024. The Net Profit increased by 1.920.384 euro, from 0 euro in 2023, to 1.920.384 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Sandoz Pharmaceuticals S.r.l.

Rating financiar

Financial Rating -
SANDOZ PHARMACEUTICALS S.R.L.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Sandoz Pharmaceuticals S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Sandoz Pharmaceuticals S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Sandoz Pharmaceuticals S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Sandoz Pharmaceuticals S.r.l. - CUI 47071873

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets - - - - - - - 0 1.784.210 1.190.157
Current Assets - - - - - - - 20.037 55.698.633 82.401.766
Inventories - - - - - - - 0 16.941.183 23.233.339
Receivables - - - - - - - 0 38.742.180 55.994.841
Cash - - - - - - - 20.037 15.270 3.173.586
Shareholders Funds - - - - - - - 19.042 20.745.518 22.665.826
Social Capital - - - - - - - 20.278 17.391.625 17.294.428
Debts - - - - - - - 995 36.234.299 60.221.816
Income in Advance - - - - - - - 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4646 - 4646"
CAEN Financial Year 4646
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 82.401.766 euro in 2024 which includes Inventories of 23.233.339 euro, Receivables of 55.994.841 euro and cash availability of 3.173.586 euro.
The company's Equity was valued at 22.665.826 euro, while total Liabilities amounted to 60.221.816 euro. Equity increased by 2.036.250 euro, from 20.745.518 euro in 2023, to 22.665.826 in 2024.

Risk Reports Prices

Reviews - Sandoz Pharmaceuticals S.r.l.

Comments - Sandoz Pharmaceuticals S.r.l.

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.